Professor of Clinical Immunology at the Department of Laboratory Medicine
Lennart Hammarström earned his Ph.D. from Karolinska Institutet in 1979, and became professor in 1997. He has been working on various aspects of clinical immunology for the past 30 years, concentrating on the genetics of immunodeficiency diseases/autoimmune diseases and different forms of immunotheraphy for these patient categories.
Lennart Hammarström has been contributing to these fields by identifying several novel genes associated with antibody deficiency diseases. In the immunotheraphy field, he has pioneered the use of novel sources of antibodies and antibody fragments for therapeutic use in immunodeficiency patients, using genetically engineered lactic acid bacteria for prophylaxis and therapy in infections affecting mucosal sites.
Lately, his work has concentrated on the genetics of IgA deficiency, the most common primary immunodeficiency in the Western world and the introduction of neonatal screening for PID in Sweden.